USPTO Patent Application: CD70 Antibody Drug Conjugates
Summary
The USPTO has published a new patent application (US20260083853A1) detailing CD70 antibody drug conjugates for treating cancer and autoimmune diseases. The application was filed on October 25, 2023, by inventors Xiao Shang and others.
What changed
This document is a USPTO patent application (US20260083853A1) for "CD70 antibody drug conjugates and methods of using the same" for the treatment of cancer and autoimmune diseases. The application was filed on October 25, 2023, by inventors Xiao Shang, Haidong Liu, Julia Gavrilyuk, Baiteng Zhao, Tae Han, and Zhu Chen.
As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in therapeutic agents and may be of interest to pharmaceutical and biotechnology companies for competitive intelligence and R&D strategy. No compliance actions or deadlines are associated with this filing.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME
Application US20260083853A1 Kind: A1 Mar 26, 2026
Inventors
Xiao SHANG, Haidong LIU, Julia GAVRILYUK, Baiteng ZHAO, Tae HAN, Zhu CHEN
Abstract
The present invention provides conjugates of CD70 antibodies, and/or antigen binding portions thereof, for use in the treatment of cancer and autoimmune disease.
CPC Classifications
A61K 47/68037 A61K 47/68031 A61K 47/6849 A61K 47/6851 A61K 47/6889 A61P 35/00 C07K 16/2875
Filing Date
2023-10-25
Application No.
19123878
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.